|
|
1.
|
NASODINE
| Numéro d'application |
1836082 |
| Statut |
Enregistrée |
| Date de dépôt |
2024-12-16 |
| Date d'enregistrement |
2024-12-16 |
| Propriétaire |
Firebrick Pharma Limited (Australie)
|
| Classes de Nice ? |
05 - Produits pharmaceutiques, vétérinaires et hygièniques
|
Produits et services
Antimicrobial nasal sprays and rinses, antimicrobial throat
gargles, sprays and washes, antimicrobial sprays and rinses
for administration to the ear, antimicrobial body washes and
soaps, antimicrobial skin cleansers, antimicrobial sprays
and rinses for topical use, topical formulations containing
povidone iodine.
|
2.
|
NASODINE
| Numéro de série |
98281139 |
| Statut |
Enregistrée |
| Date de dépôt |
2023-11-21 |
| Date d'enregistrement |
2025-08-05 |
| Propriétaire |
Firebrick Pharma Limited (Australie)
|
| Classes de Nice ? |
03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser.
|
Produits et services
Sanitary preparations being non-medicated toiletry preparations; unmedicated nasal cleaning preparations for personal sanitary purposes
|
3.
|
IMPROVED VIRUCIDAL FORMULATIONS
| Numéro d'application |
18001343 |
| Statut |
En instance |
| Date de dépôt |
2021-06-10 |
| Date de la première publication |
2023-07-27 |
| Propriétaire |
FIREBRICK PHARMA LIMITED (Australie)
|
| Inventeur(s) |
- Molloy, Peter
- Tucker, Simon
- Goodall, Stephen
|
Abrégé
The present invention is directed to PVP-I formulations having enhanced virucidal activity. The formulations are intended for topical administration for treatment and/or decreased risk of microbial infections in subjects. The formulations include PVP-I and other ingredients selected to enhance the virucidal activity of the formulation over PVP-I alone.
Classes IPC ?
- A61K 33/18 - IodeSes composés
- A61K 47/10 - AlcoolsPhénolsLeurs sels, p. ex. glycérolPolyéthylène glycols [PEG]PoloxamèresAlkyléthers de PEG/POE
- A61K 47/32 - Composés macromoléculaires obtenus par des réactions faisant intervenir uniquement des liaisons non saturées carbone-carbone, p. ex. carbomères
- A61P 31/16 - Antiviraux pour le traitement des virus ARN de la grippe ou des rhinovirus
- A61P 31/14 - Antiviraux pour le traitement des virus ARN
|
4.
|
Prevention of infection by highly pathogenic viruses using topical application of povidone-iodine on mucous membranes
| Numéro d'application |
17544926 |
| Numéro de brevet |
11969441 |
| Statut |
Délivré - en vigueur |
| Date de dépôt |
2021-12-07 |
| Date de la première publication |
2022-06-02 |
| Date d'octroi |
2024-04-30 |
| Propriétaire |
FIREBRICK PHARMA LIMITED (Australie)
|
| Inventeur(s) |
- Molloy, Peter
- Goodall, Stephen
|
Abrégé
This invention is directed to methods for prevention of infections by highly pathogenic viruses by applying to the nasal mucous membranes topical preparations comprising the broad-spectrum antimicrobial agent povidone-iodine.
Classes IPC ?
- A61K 31/79 - Polymères de vinylpyrrolidone
- A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
- A61K 9/08 - Solutions
- A61K 9/127 - Vecteurs à bicouches synthétiques, p. ex. liposomes ou liposomes comportant du cholestérol en tant qu’unique agent tensioactif non phosphatidylique
- A61K 33/18 - IodeSes composés
- A61K 47/32 - Composés macromoléculaires obtenus par des réactions faisant intervenir uniquement des liaisons non saturées carbone-carbone, p. ex. carbomères
- A61P 31/04 - Agents antibactériens
- A61P 31/12 - Antiviraux
- A61P 31/14 - Antiviraux pour le traitement des virus ARN
- A61P 31/16 - Antiviraux pour le traitement des virus ARN de la grippe ou des rhinovirus
|
5.
|
F FirebrickPharma
| Numéro d'application |
1655752 |
| Statut |
Enregistrée |
| Date de dépôt |
2022-03-07 |
| Date d'enregistrement |
2022-03-07 |
| Propriétaire |
Firebrick Pharma Limited (Australie)
|
| Classes de Nice ? |
05 - Produits pharmaceutiques, vétérinaires et hygièniques
|
Produits et services
Pharmaceutical preparations; anti-bacterial pharmaceutical
preparations; iodine for pharmaceutical purposes;
pharmaceutical preparations for health care; pharmaceutical
preparations for human use; pharmaceutical preparations for
nasal use; pharmaceutical preparations for oral use;
pharmaceutical preparations for personal use; pharmaceutical
preparations for topical use; pharmaceutical products;
pharmaceutical products for use by humans; preparations for
application to the body (pharmaceuticals); pharmaceutical
preparations in nasal spray form; pharmaceutical
preparations for the skin, nails, scalp and body.
|
6.
|
F FIREBRICKPHARMA
| Numéro d'application |
217936800 |
| Statut |
Enregistrée |
| Date de dépôt |
2022-03-07 |
| Date d'enregistrement |
2025-01-17 |
| Propriétaire |
Firebrick Pharma Limited (Australie)
|
| Classes de Nice ? |
05 - Produits pharmaceutiques, vétérinaires et hygièniques
|
Produits et services
(1) Pharmaceutical preparations for the treatment and prevention of bacterial and viral infections and diseases, namely, antibacterials, antibiotics, antifungals, antiparasitics, and antivirals; Pharmaceutical preparations for the treatment and prevention of dandruff; Pharmaceutical preparations for the treatment and prevention of bacteria that causes body odour; Pharmaceutical preparations for the treatment and prevention of respiratory diseases; Pharmaceutical preparations for the treatment and prevention of skin diseases, namely, diaper rash, heat rashes, hemorrhoids, chafed skin, minor burns, bed sores, abrasions, shingles, chapped lips, incontinent rashes, poison ivy and oak, rectal itching and fever blisters; Pharmaceutical preparations for the treatment and prevention of nail fungus; anti-bacterial pharmaceutical preparations namely antibacterials, antibacterial spray; iodine for pharmaceutical purposes; pharmaceutical preparations for health care for the treatment and prevention of bacterial and viral infections and diseases, namely, antibacterials, antibiotics, antifungals, antiparasitics, and antivirals for health care; pharmaceutical preparations for human use for the treatment and prevention of bacterial and viral infections and diseases, namely, antibacterials, antibiotics, antifungals, antiparasitics, and antivirals for human use; pharmaceutical preparations for nasal use for the treatment and prevention of bacterial and viral infections and diseases, namely, antibacterials, antibiotics, antifungals, antiparasitics, and antivirals for nasal use; pharmaceutical preparations for oral use for the treatment and prevention of bacterial and viral infections and diseases, namely, antibacterials, antibiotics, antifungals, antiparasitics, and antivirals for oral use; pharmaceutical preparations for personal use for the treatment and prevention of bacterial and viral infections and diseases, namely, antibacterials, antibiotics, antifungals, antiparasitics, and antivirals for personal use; pharmaceutical preparations for topical use for the treatment and prevention of bacterial and viral infections and diseases, namely, antibacterials, antibiotics, antifungals, antiparasitics, and antivirals for topical use; pharmaceutical products for the treatment and prevention of bacterial and viral infections and diseases, namely, antibacterials, antibiotics, antifungals, antiparasitics, and antivirals; pharmaceutical products for use by humans for the treatment and prevention of bacterial and viral infections and diseases, namely, antibacterials, antibiotics, antifungals, antiparasitics, and antivirals for use by humans; pharmaceutical preparations for application to the body for the treatment and prevention of bacterial and viral infections and diseases, namely, antibacterials, antibiotics, antifungals, antiparasitics, and antivirals for topical use; pharmaceutical preparations in nasal spray form for the treatment and prevention of bacterial and viral infections and diseases, namely, antibacterials, antibiotics, antifungals, antiparasitics, and antivirals in nasal spray form; pharmaceutical preparations for the skin, nails, scalp and body for the treatment and prevention of bacterial and viral infections and diseases, namely, antibacterials, antibiotics, antifungals, antiparasitics, and antivirals for the skin, nails, scalp, and body.
|
7.
|
F FIREBRICKPHARMA
| Numéro de série |
79338107 |
| Statut |
Enregistrée |
| Date de dépôt |
2022-03-07 |
| Date d'enregistrement |
2023-09-12 |
| Propriétaire |
Firebrick Pharma Limited (Australie)
|
| Classes de Nice ? |
05 - Produits pharmaceutiques, vétérinaires et hygièniques
|
Produits et services
Pharmaceutical preparations for the treatment and prevention of bacterial and viral infections and diseases; Pharmaceutical preparations for the treatment and prevention of dandruff; Pharmaceutical preparations for the treatment and prevention of bacteria that causes body odour; Pharmaceutical preparations for the treatment and prevention of respiratory diseases; Pharmaceutical preparations for the treatment and prevention of skin diseases; Pharmaceutical preparations for the treatment and prevention of nail fungus; anti-bacterial pharmaceutical preparations; iodine for pharmaceutical purposes; pharmaceutical preparations for health care for the treatment and prevention of bacterial and viral infections and diseases; pharmaceutical preparations for human use for the treatment and prevention of bacterial and viral infections and diseases; pharmaceutical preparations for nasal use for the treatment and prevention of bacterial and viral infections and diseases; pharmaceutical preparations for oral use for the treatment and prevention of bacterial and viral infections and diseases; pharmaceutical preparations for personal use for the treatment and prevention of bacterial and viral infections and diseases; pharmaceutical preparations for topical use for the treatment and prevention of bacterial and viral infections and diseases; pharmaceutical products for the treatment and prevention of bacterial and viral infections and diseases; pharmaceutical products for use by humans for the treatment and prevention of bacterial and viral infections and diseases; pharmaceutical preparations for application to the body for the treatment and prevention of bacterial and viral infections and diseases; pharmaceutical preparations in nasal spray form for the treatment and prevention of bacterial and viral infections and diseases; pharmaceutical preparations for the skin, nails, scalp and body for the treatment and prevention of bacterial and viral infections and diseases
|
8.
|
IMPROVED VIRUCIDAL FORMULATIONS
| Numéro d'application |
AU2021050590 |
| Numéro de publication |
2021/248196 |
| Statut |
Délivré - en vigueur |
| Date de dépôt |
2021-06-10 |
| Date de publication |
2021-12-16 |
| Propriétaire |
FIREBRICK PHARMA LIMITED (Australie)
|
| Inventeur(s) |
- Molloy, Peter
- Tucker, Simon
- Goodall, Stephen
|
Abrégé
The present invention is directed to PVP-I formulations having enhanced virucidal activity. The formulations are intended for topical administration for treatment and/or decreased risk of microbial infections in subjects. The formulations include PVP-I and other ingredients selected to enhance the virucidal activity of the formulation over PVP-I alone.
Classes IPC ?
- A61K 33/18 - IodeSes composés
- A61K 31/79 - Polymères de vinylpyrrolidone
- A61K 31/045 - Composés hydroxylés, p. ex. alcoolsLeurs sels, p. ex. alcoolates
- A61P 31/04 - Agents antibactériens
- A61P 31/12 - Antiviraux
- A61P 31/14 - Antiviraux pour le traitement des virus ARN
- A61P 31/16 - Antiviraux pour le traitement des virus ARN de la grippe ou des rhinovirus
|
9.
|
Xilodine
| Numéro d'application |
1587776 |
| Statut |
Enregistrée |
| Date de dépôt |
2021-03-30 |
| Date d'enregistrement |
2021-03-30 |
| Propriétaire |
Firebrick Pharma Ltd (Australie)
|
| Classes de Nice ? |
05 - Produits pharmaceutiques, vétérinaires et hygièniques
|
Produits et services
Iodine for pharmaceutical purposes; pharmaceutical
preparations for skin care; pharmaceutical preparations for
treating dandruff; topical pharmaceutical preparations; nail
fungus treatment preparations; antibacterial pharmaceutical
preparations; antiseptic preparations.
|
10.
|
Xilodine
| Numéro d'application |
210166900 |
| Statut |
Enregistrée |
| Date de dépôt |
2021-03-30 |
| Date d'enregistrement |
2023-03-01 |
| Propriétaire |
Firebrick Pharma Ltd (Australie)
|
| Classes de Nice ? |
05 - Produits pharmaceutiques, vétérinaires et hygièniques
|
Produits et services
(1) Iodine for pharmaceutical purposes; pharmaceutical preparations for skin care namely medicated skin care preparations for treating body odor; pharmaceutical preparations for treating dandruff; medicated topical skin preparations containing iodine; pharmaceutical preparations for skin care containing iodine; nail fungus treatment preparations; antibacterials; antiseptic preparations
|
11.
|
XILODINE
| Numéro de série |
79309392 |
| Statut |
Enregistrée |
| Date de dépôt |
2021-03-30 |
| Date d'enregistrement |
2022-08-16 |
| Propriétaire |
Firebrick Pharma Ltd (Australie)
|
| Classes de Nice ? |
05 - Produits pharmaceutiques, vétérinaires et hygièniques
|
Produits et services
Iodine for pharmaceutical purposes; pharmaceutical preparations for skin care; pharmaceutical preparations for treating dandruff; topical pharmaceutical preparations for the treatment of and elimination of bacteria that causes body odour; nail fungus treatment preparations; antibacterial pharmaceutical preparations; antiseptic preparations
|
12.
|
Prevention of infection by highly pathogenic viruses using topical application of povidone-iodine on mucous membranes
| Numéro d'application |
16925740 |
| Numéro de brevet |
11246887 |
| Statut |
Délivré - en vigueur |
| Date de dépôt |
2020-07-10 |
| Date de la première publication |
2020-12-10 |
| Date d'octroi |
2022-02-15 |
| Propriétaire |
FIREBRICK PHARMA LIMITED (Australie)
|
| Inventeur(s) |
- Molloy, Peter
- Goodall, Stephen
|
Abrégé
This invention is directed to methods for prevention of infections by highly pathogenic viruses by applying to the nasal mucous membranes topical preparations comprising the broad-spectrum antimicrobial agent povidone-iodine.
Classes IPC ?
- A61K 31/79 - Polymères de vinylpyrrolidone
- A61P 31/12 - Antiviraux
- A61P 31/14 - Antiviraux pour le traitement des virus ARN
- A61P 31/16 - Antiviraux pour le traitement des virus ARN de la grippe ou des rhinovirus
- A61P 31/04 - Agents antibactériens
- A61K 33/18 - IodeSes composés
- A61K 47/32 - Composés macromoléculaires obtenus par des réactions faisant intervenir uniquement des liaisons non saturées carbone-carbone, p. ex. carbomères
- A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
- A61K 9/08 - Solutions
- A61K 9/127 - Vecteurs à bicouches synthétiques, p. ex. liposomes ou liposomes comportant du cholestérol en tant qu’unique agent tensioactif non phosphatidylique
|
13.
|
Nasodine
| Numéro d'application |
1545551 |
| Statut |
Enregistrée |
| Date de dépôt |
2020-07-14 |
| Date d'enregistrement |
2020-07-14 |
| Propriétaire |
Firebrick Pharma Limited (Australie)
|
| Classes de Nice ? |
05 - Produits pharmaceutiques, vétérinaires et hygièniques
|
Produits et services
Anti-bacterial pharmaceutical preparations; iodine for
pharmaceutical purposes; pharmaceutical preparations;
pharmaceutical preparations for health care; pharmaceutical
preparations for human use; pharmaceutical preparations for
nasal use; pharmaceutical preparations for oral use;
pharmaceutical preparations for personal use; pharmaceutical
preparations for topical use; pharmaceutical products;
pharmaceutical products for use by humans; preparations for
application to the body (pharmaceuticals).
|
14.
|
NASODINE
| Numéro de série |
79291643 |
| Statut |
Enregistrée |
| Date de dépôt |
2020-07-14 |
| Date d'enregistrement |
2021-03-30 |
| Propriétaire |
Firebrick Pharma Limited (Australie)
|
| Classes de Nice ? |
05 - Produits pharmaceutiques, vétérinaires et hygièniques
|
Produits et services
Pharmaceutical preparations for nasal use; pharmaceutical preparations for the treatment and prevention of infections of the nose and throat; pharmaceutical preparations for the treatment and prevention of viral infections
|
15.
|
Nasodine
| Numéro d'application |
204557100 |
| Statut |
Enregistrée |
| Date de dépôt |
2020-07-14 |
| Date d'enregistrement |
2023-07-12 |
| Propriétaire |
Firebrick Pharma Limited (Australie)
|
| Classes de Nice ? |
05 - Produits pharmaceutiques, vétérinaires et hygièniques
|
Produits et services
(1) Anti-bacterial pharmaceutical preparations namely antibacterials, antibacterial spray; iodine for pharmaceutical purposes; pharmaceutical preparations namely anti-viral agents, pharmaceutical preparations for the treatment of infectious diseases namely respiratory infections, pharmaceutical preparations for the treatment of respiratory diseases, disorders and infections, pharmaceutical preparations for the treatment of viral diseases namely influenza, rhinovirus, pneumonia and the common cold, pharmaceutical preparations for the treatment of viral infections namely influenza, rhinovirus, pneumonia and the common cold, pharmaceuticals for the treatment of coronavirus diseases and COVID-19
|
16.
|
Vironase
| Numéro d'application |
1521777 |
| Statut |
Enregistrée |
| Date de dépôt |
2020-02-24 |
| Date d'enregistrement |
2020-02-24 |
| Propriétaire |
Firebrick Pharma Limited (Australie)
|
| Classes de Nice ? |
05 - Produits pharmaceutiques, vétérinaires et hygièniques
|
Produits et services
Anti-bacterial pharmaceutical preparations; iodine for
pharmaceutical purposes; iodine for medical purposes;
medical preparations; medicated antiseptic preparations for
application to the skin; pharmaceutical preparations;
pharmaceutical preparations for health care; pharmaceutical
preparations for nasal use; pharmaceutical preparations for
oral use; pharmaceutical preparations for human use;
pharmaceutical preparations for personal use; pharmaceutical
preparations for topical use; pharmaceutical products;
pharmaceutical products for use by humans; preparations for
application to the body (pharmaceuticals); preparations for
combating attack by microbial pests; sprays (preparations)
for the body (for medical use); sprays for use on the body
(pharmaceuticals); nasal washes.
|
17.
|
Nasodine
| Numéro d'application |
1435625 |
| Statut |
Enregistrée |
| Date de dépôt |
2018-10-10 |
| Date d'enregistrement |
2018-10-10 |
| Propriétaire |
Firebrick Pharma Limited (Australie)
|
| Classes de Nice ? |
05 - Produits pharmaceutiques, vétérinaires et hygièniques
|
Produits et services
Anti-bacterial pharmaceutical preparations; iodine for
pharmaceutical purposes; pharmaceutical preparations;
pharmaceutical preparations for health care; pharmaceutical
preparations for human use; pharmaceutical preparations for
nasal use; pharmaceutical preparations for oral use;
pharmaceutical preparations for personal use; pharmaceutical
preparations for topical use; pharmaceutical products;
pharmaceutical products for use by humans; preparations for
application to the body (pharmaceuticals).
|
18.
|
Treatment and prevention of the common cold using povidone-iodine
| Numéro d'application |
15327998 |
| Numéro de brevet |
11000542 |
| Statut |
Délivré - en vigueur |
| Date de dépôt |
2015-07-06 |
| Date de la première publication |
2017-06-15 |
| Date d'octroi |
2021-05-11 |
| Propriétaire |
FIREBRICK PHARMA LIMITED (Australie)
|
| Inventeur(s) |
- Goodall, Stephen
- Molloy, Peter
|
Abrégé
The present invention provides a method of treating and preventing the common cold and associated secondary illnesses in a human subject, when the common cold is caused by viruses. The method comprises applying to the nasal passages of the human subject at ambient temperature, an effective amount of a pharmaceutical preparation comprising povidone-iodine (PVP-I) at a concentration of greater than 0.10% w/v and less than 2.5% in which at least 50% of the PVP-I is not associated with liposomes or other particulate carriers.
Classes IPC ?
- A61K 33/18 - IodeSes composés
- A61K 31/79 - Polymères de vinylpyrrolidone
- A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
- A61P 31/16 - Antiviraux pour le traitement des virus ARN de la grippe ou des rhinovirus
- A61P 31/14 - Antiviraux pour le traitement des virus ARN
- A61P 31/12 - Antiviraux
- A61K 45/06 - Mélanges d'ingrédients actifs sans caractérisation chimique, p. ex. composés antiphlogistiques et pour le cœur
|
|